Clinical Trial Detail

NCT ID NCT03360006
Title A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Subjects With Advanced Prostate Cancer (CRPC) and Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications

acute myeloid leukemia

prostate cancer

Therapies

ABBV-744

Age Groups: adult senior

No variant requirements are available.